Current Treatment Options for Metastatic Non-Small Cell Lung Cancer

This chapter explores the latest developments in targeted therapies for metastatic non-small cell lung cancer, focusing on actionable mutations like EGFR and ALK. It highlights first-line treatment options, their efficacy, and important side effects, underscoring the dynamic nature of cancer treatment.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app